BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Receives USPTO Notice of Allowance for Abuse-Deterrent Fentanyl Patch Brand Names
Nutriband (NASDAQ: NTRB) announced that it received a Notice of Allowance dated Nov. 3, 2026, from the United States Patent and Trademark Office ("USPTO") for commercial brand name trademarks associated with its lead abuse-deterrent fentanyl transdermal system. The company intends to pursue full trademark registration in the United States and internationally and is preparing to submit its proposed global brand name to the U.S. Food and Drug Administration ("FDA"), European Medicines Agency ("EMA") and other regulatory authorities for preapproval review. Nutriband said its naming process emphasizes minimizing potential medication errors associated with similar-looking or similar-sounding drug names. The company's lead…











